Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004822:Epididymis / Q000166:cytology; D004837:Epinephrine / Q000494:pharmacology*; D005934:Glucagon / Q000494:pharmacology; D005990:Glycerol / Q000096:biosynthesis; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D050356:Lipid Metabolism; D008297:Male; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D000227:Adenine Nucleotides; D007328:Insulin; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D005990:Glycerol; D004837:Epinephrine